Business Segments · Depreciation
Cardiovascular — Depreciation
Boston Scientific Cardiovascular — Depreciation increased by 18.0% to $105.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $90.00M to $105.00M. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Depreciation shows an upward trend with a 20.7% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
An increase may signal significant capital investment in new manufacturing facilities or equipment for the cardiovascular segment.
Detailed definition
This metric tracks the systematic allocation of the cost of tangible assets used specifically within the cardiovascular...
Peer comparison
Similar to 'Segment Depreciation and Amortization' reported by peers in capital-intensive manufacturing sectors.
Metric ID:
bsx_segment_cardiovascular_depreciationHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.75M | $41.75M | $41.75M | $61.25M | $61.25M | $61.25M | $61.25M | $65.75M | $65.75M | $65.75M | $65.75M | $66.00M | $71.00M | $75.00M | $90.00M | $78.00M | $83.00M | $89.00M | $105.00M |
| QoQ Change | — | +0.0% | +0.0% | +46.7% | +0.0% | +0.0% | +0.0% | +7.3% | +0.0% | +0.0% | +0.0% | +0.4% | +7.6% | +5.6% | +20.0% | -13.3% | +6.4% | +7.2% | +18.0% |
| YoY Change | — | — | — | — | +46.7% | +46.7% | +46.7% | +7.3% | +7.3% | +7.3% | +7.3% | +0.4% | +8.0% | +14.1% | +36.9% | +18.2% | +16.9% | +18.7% | +16.7% |
Range$41.75M – $105.00M
CAGR+22.7%
Avg YoY Growth+19.9%
Median YoY Growth+16.7%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — depreciation?
- Boston Scientific (BSX) reported cardiovascular — depreciation of $105.00M in Q4 2025.
- How has Boston Scientific's cardiovascular — depreciation changed year-over-year?
- Boston Scientific's cardiovascular — depreciation increased by 16.7% year-over-year, from $90.00M to $105.00M.
- What is the long-term trend for Boston Scientific's cardiovascular — depreciation?
- Over 4 years (2021 to 2025), Boston Scientific's cardiovascular — depreciation has grown at a 20.7% compound annual growth rate (CAGR), from $167.00M to $355.00M.
- What does cardiovascular — depreciation mean?
- The portion of cardiovascular segment asset costs recognized as an expense during the period.